SEC Form D · filed October 13, 2022
Enlaza Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Sanford Madigan · La Jolla, CAExecJay Lichter · La Jolla, CADirectorMarcos Milla · La Jolla, CADirectorShelley Chu · La Jolla, CADirectorSergio Duron · La Jolla, CAExec · DirectorJames N. Topper · La Jolla, CADirectorTighe Reardon · La Jolla, CAExecTyler M. Whitmore · Nashville, TNDirectorMark S. Rosen · Morristown, NJDirectorChristopher Rand · Nashville, TNDirectorRegan Bozman · San Francisco, CAExec · DirectorByron M. Smith · Nashville, TNExecBrian M. Laden · Nashville, TNDirectorGerard M. Hayden, Jr · Nashville, TNExecMarc Chalfin · Miami Beach, FLExec · DirectorTheodore Woo · Miami Beach, FLExecMarc Chalfin · Miami Beach, FLExecEric C. Harweger · Ames, IADirectorDavid R. Phaup · Edwardsville, ILDirectorBruce E. Schneider · Venedy, ILDirectorMike D. Christensen · Edwardsville, ILDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗